SecurityWBK / Westpac Banking Corp. Ltd. (961214301)
Form 6-K Count201
Form 424B2 Count77
Form 424B5 Count41
Form FWP Count35

SEC Filings - 10K, 8K, Annual Reports

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Westpac Banking Corp. Ltd.


DateFormTitle
2018-06-08 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-28 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-18 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-15 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-10 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2018-05-09 FWP WBK / Westpac Banking Corp. Ltd. FWP
2018-05-08 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2018-05-08 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-08 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-08 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-05-07 FWP WBK / Westpac Banking Corp. Ltd. FWP
2018-05-01 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-04-26 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-03-26 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-02-14 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-02-07 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-02-05 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-02-01 SC 13G WBK / Westpac Banking Corp. Ltd. / BlackRock Inc. - 3G (Passive Investment)
2018-02-01 SC 13G WBK / Westpac Banking Corp. Ltd. / BlackRock Inc. - 3G (Passive Investment)
2018-02-01 ABS-15G WBK / Westpac Banking Corp. Ltd. ABS-15G
2018-01-25 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2018-01-19 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2018-01-18 FWP WBK / Westpac Banking Corp. Ltd. 424B8
2018-01-17 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2017-12-20 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-12-14 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-12-12 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-12-06 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2017-12-05 FWP WBK / Westpac Banking Corp. Ltd. FWP
2017-12-04 424B5 WBK / Westpac Banking Corp. Ltd. 424B5 (Prospectus)
2017-11-30 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-30 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-13 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-09 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-08 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-08 20-F WBK / Westpac Banking Corp. Ltd. 20-F
2017-11-07 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-06 FWP WBK / Westpac Banking Corp. Ltd. FWP
2017-11-04 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-11-04 6-K WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)
2017-10-19 6-K Westpac Banking 6-K (Current Report of Foreign Issuer)
2017-10-06 424B3 Westpac Banking 424B2 (Prospectus)
2017-09-21 6-K Westpac Banking 6-K (Current Report of Foreign Issuer)
2017-09-14 424B5 Westpac Banking 424B5 (Prospectus)
2017-09-13 FWP Westpac Banking FWP
2017-09-08 424B5 Westpac Banking 424B5 (Prospectus)
2017-09-07 F-3ASR Westpac Banking F-3ASR
2017-08-22 6-K Westpac Banking 6-K (Current Report of Foreign Issuer)
2017-08-22 6-K Westpac Banking 6-K (Current Report of Foreign Issuer)
2017-08-21 6-K Westpac Banking 6-K (Current Report of Foreign Issuer)

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 961214301